
Company Info
Phone(843) 965-8333
Year Established
2019
Ticker
LGND
Exchange
NASDAQ
Contacts
Todd C. DavisCEO
Tavo Espinoza
CFO
Andrew Reardon
CLO
Andrew Reardon
CLO
Matthew Korenberg
President & COO
Keith Haney
VP, Operations
Company Description
Ligand, formerly Progenx, is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.